NYMOX PHARMACEUTICAL CORP·4

Nov 6, 5:33 PM ET

Averback Paul 4

4 · NYMOX PHARMACEUTICAL CORP · Filed Nov 6, 2018

Insider Transaction Report

Form 4
Period: 2018-10-26
Averback Paul
DirectorCEO10% Owner
Transactions
  • Sale

    Restricted Common

    2018-10-26$1.75/sh100,000$175,00023,331,448 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT